UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

A novel schedule of erlotinib/capecitabine (7/7) as salvage therapy in previously treated advanced pancreatic adenocarcinoma: a case series

Therapeutic advances in gastroenterology, 2016-03, Vol.9 (2), p.162-168

2016

Link zum Volltext

Verfügbarkeit prüfen

Safety and feasibility of systemic anticancer therapy in gastrointestinal (GI) cancer patients on hemodialysis (HD): The largest retrospective study

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e16139-e16139

2020

Link zum Volltext

Verfügbarkeit prüfen

A retrospective study of capecitabine/temozolomide (CAPTEM) regimen in the treatment of metastatic pancreatic neuroendocrine tumors (pNETs) after failing previous therapy

Journal of the Pancreas, 2013-09, Vol.14 (5), p.498

2013

Link zum Volltext

Verfügbarkeit prüfen

Role of Pregabalin in Treatment of Oxaliplatin-induced Sensory Neuropathy

Anticancer research, 2010-07, Vol.30 (7), p.2927-2933

2010

Link zum Volltext

Verfügbarkeit prüfen

First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer

Cancer chemotherapy and pharmacology, 2014-02, Vol.73 (2), p.373-380

2014

Link zum Volltext

Verfügbarkeit prüfen

Gastrointestinal stromal tumor of colon: a case report and review of literature

Anticancer research, 2014-05, Vol.34 (5), p.2547-2550

2014

Link zum Volltext

Verfügbarkeit prüfen

Bone Metastasis as the Only Metastatic Site in a Patient with Pancreatic Cancer following Distal Pancreatectomy

Case Reports in Medicine, 2010-01, Vol.2010, p.1-3

2010

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes in pancreatic adenocarcinoma associated with BRCA-2 mutation

Anti-cancer drugs, 2015-02, Vol.26 (2), p.224-226

2015

Link zum Volltext

Verfügbarkeit prüfen

Mitomycin-C and capecitabine (MIXE) as salvage treatment in patients with refractory metastatic colorectal cancer: a retrospective study

Anticancer research, 2013-06, Vol.33 (6), p.2743-2746

2013

Link zum Volltext

Verfügbarkeit prüfen

Docetaxel Second-line Therapy in Patients with Advanced Pancreatic Cancer: A Retrospective Study

Anticancer research, 2010-07, Vol.30 (7), p.2905-2909

2010

Link zum Volltext

Verfügbarkeit prüfen

Gastrointestinal stromal tumors of the pancreas

Journal of the Pancreas, 2010-07, Vol.11 (4), p.405

2010

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of Panitumumab Therapy After Progression With Cetuximab: Experience at Two Institutions

Clinical colorectal cancer, 2010-12, Vol.9 (5), p.315-318

2010

Link zum Volltext

Verfügbarkeit prüfen

Chronic octreotide therapy can induce pancreatic insufficiency: a common but under-recognized adverse effect

Expert opinion on drug safety, 2010-11, Vol.9 (6), p.867-873

2010

Link zum Volltext

Verfügbarkeit prüfen

Interim analysis of a phase II study of dose-modified FOLFIRINOX (mFOLFIRINOX) in locally advanced (LAPC) and metastatic pancreatic cancer (MPC)

Journal of clinical oncology, 2014-01, Vol.32 (3_suppl), p.256-256

2014

Link zum Volltext

Verfügbarkeit prüfen

Final analysis of a phase II study of Yale-modified FOLFIRINOX (mFOLFIRINOX) in metastatic pancreatic cancer (MPC)

Journal of clinical oncology, 2015-01, Vol.33 (3_suppl), p.395-395

2015

Link zum Volltext

Verfügbarkeit prüfen

Interim analysis of a phase II study of dose-modified FOLFIRINOX (mFOLFIRINOX) in locally advanced (LAPC) and metastatic pancreatic cancer (MPC)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e15226-e15226

2014

Link zum Volltext

Verfügbarkeit prüfen

Gemcitabine as salvage treatment in patients with poorly differentiated pancreatic neuroendocrine tumors: a case series

Journal of the Pancreas, 2014-01, Vol.15 (1), p.38-41

2014

Link zum Volltext

Verfügbarkeit prüfen

The Efficacy of Gemcitabine as Salvage Treatment in Patients with Refractory Advanced Colorectal Cancer (CRC): A Single Institution Experience

Anticancer research, 2011-09, Vol.31 (9), p.2971-2974

2011

Link zum Volltext

Verfügbarkeit prüfen

Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinoma

Oncology letters, 2014-09, Vol.8 (3), p.1302-1306

2014

Link zum Volltext

Verfügbarkeit prüfen

Single-institution experience with FOLFIRINOX in advanced pancreatic cancer (PC)

Journal of clinical oncology, 2012-02, Vol.30 (4_suppl), p.330-330

2012

Link zum Volltext

Verfügbarkeit prüfen

Pancreatic adenocarcinoma with supraclavicular lymph node metastasis: is this the Virchow's node?

Journal of the Pancreas, 2011-01, Vol.12 (1), p.66-7; author reply 70

2011

Link zum Volltext

Verfügbarkeit prüfen

Sweeping KRAS generalizations: are we depriving patients of an effective treatment? A novel KRAS mutation and dramatic response to panitumumab in a patient with metastatic colorectal cancer

International journal of colorectal disease, 2011-10, Vol.26 (10), p.1353-1354

2011

Link zum Volltext

Verfügbarkeit prüfen

Staphylococcus aureus bacteremia related with erlotinib skin toxicity in a patient with pancreatic cancer

Journal of the Pancreas, 2009-05, Vol.10 (3), p.338

2009

Link zum Volltext

Verfügbarkeit prüfen

Rash associated with the use of pegylated filgrastim in a patient with advanced pancreatic cancer

Cutaneous and ocular toxicology, 2009-12, Vol.28 (4), p.181-184

2009

Link zum Volltext

Verfügbarkeit prüfen

First case report associating gemcitabine with hypersensitivity reaction in a patient with pancreatic cancer

Journal of the Pancreas, 2010-05, Vol.11 (3), p.273

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Englisch
(55)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(31)
Life Sciences & Biomedicine
(30)
Humans
(27)
Female
(22)
Middle Aged
(17)
Male
(16)
Aged
(13)
Gastroenterology & Hepatology
(11)
Deoxycytidine - Analogs & Derivatives
(10)
Pancreatic Neoplasms
(10)
Pancreatic Neoplasms - Drug Therapy
(10)
Oncology
(9)
Capecitabine
(8)
Deoxycytidine - Adverse Effects
(8)
Gemcitabine
(8)
Pancreatic Neoplasms - Pathology
(8)
Adult
(7)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(7)
Treatment Outcome
(7)
Antineoplastic Agents - Therapeutic Use
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A novel schedule of erlotinib/capecitabine (7/7) as salvage therapy in previously treated advanced pancreatic adenocarcinoma: a case series

Safety and feasibility of systemic anticancer therapy in gastrointestinal (GI) cancer patients on hemodialysis (HD): The largest retrospective study

A retrospective study of capecitabine/temozolomide (CAPTEM) regimen in the treatment of metastatic pancreatic neuroendocrine tumors (pNETs) after failing previous therapy

Role of Pregabalin in Treatment of Oxaliplatin-induced Sensory Neuropathy

First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer

Gastrointestinal stromal tumor of colon: a case report and review of literature

Bone Metastasis as the Only Metastatic Site in a Patient with Pancreatic Cancer following Distal Pancreatectomy

Clinical outcomes in pancreatic adenocarcinoma associated with BRCA-2 mutation

Mitomycin-C and capecitabine (MIXE) as salvage treatment in patients with refractory metastatic colorectal cancer: a retrospective study

Docetaxel Second-line Therapy in Patients with Advanced Pancreatic Cancer: A Retrospective Study

Gastrointestinal stromal tumors of the pancreas

Safety and Efficacy of Panitumumab Therapy After Progression With Cetuximab: Experience at Two Institutions

Chronic octreotide therapy can induce pancreatic insufficiency: a common but under-recognized adverse effect

Interim analysis of a phase II study of dose-modified FOLFIRINOX (mFOLFIRINOX) in locally advanced (LAPC) and metastatic pancreatic cancer (MPC)

Final analysis of a phase II study of Yale-modified FOLFIRINOX (mFOLFIRINOX) in metastatic pancreatic cancer (MPC)

Interim analysis of a phase II study of dose-modified FOLFIRINOX (mFOLFIRINOX) in locally advanced (LAPC) and metastatic pancreatic cancer (MPC)

Gemcitabine as salvage treatment in patients with poorly differentiated pancreatic neuroendocrine tumors: a case series

The Efficacy of Gemcitabine as Salvage Treatment in Patients with Refractory Advanced Colorectal Cancer (CRC): A Single Institution Experience

Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinoma

Single-institution experience with FOLFIRINOX in advanced pancreatic cancer (PC)

Pancreatic adenocarcinoma with supraclavicular lymph node metastasis: is this the Virchow's node?

Sweeping KRAS generalizations: are we depriving patients of an effective treatment? A novel KRAS mutation and dramatic response to panitumumab in a patient with metastatic colorectal cancer

Staphylococcus aureus bacteremia related with erlotinib skin toxicity in a patient with pancreatic cancer

Rash associated with the use of pegylated filgrastim in a patient with advanced pancreatic cancer

First case report associating gemcitabine with hypersensitivity reaction in a patient with pancreatic cancer

Suchergebnisse filtern